Since September 19, 2016, QPS has closely collaborated with G-CURE, a cardiovascular research organization originating from and closely linked to the Department of Cardiology at…
Newark, Delaware, September 18, 2019 – QPS, a leading contract research organization (CRO), continues to expand its global footprint with new clinics in the Netherlands and…
Newark, Delaware, June 18, 2019 – QPS, a global contract research organization (CRO) providing discovery, preclinical and clinical drug development services, today announced continuing…
Newark, Delaware, May 20, 2019 – QPS, a global contract research organization (CRO) providing discovery, preclinical and clinical drug development services, has been awarded…
NEWARK, Del., May 20, 2019 /PRNewswire/ — QPS, a global contract research organization (CRO) providing discovery, preclinical and clinical drug development services, today announced…
Newark, Delaware, April 22, 2019 – QPS, a global contract research organization (CRO) providing discovery, preclinical and clinical drug development services, today announced its…
Newark, Delaware, March 25, 2019 – With Brexit pending and the European Medicines Agency (EMA) headquarters moving from London to the Netherlands, QPS, a…
Newark, Delaware, February 4, 2019 – On the heels of recent FDA approvals of gene therapies in the US market, QPS, a GLP/GCP-compliant contract…
Newark, Delaware, January 8, 2019 – The year 2019 marks 24 years of growth for QPS, LLC, a leading global CRO focused on bioanalytics…
QPS, a GLP/GCP-compliant contract research organization (CRO) supporting discovery, preclinical and clinical drug development, today announced the expansion of its U.S.-based Phase I clinical…
